BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37735371)

  • 21. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
    Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
    Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.
    Poizot-Martin I; Obry-Roguet V; Duvivier C; Lions C; Huleux T; Jacomet C; Ferry T; Cheret A; Allavena C; Bani-Sadr F; Palich R; Cabié A; Fresard A; Pugliese P; Delobel P; Lamaury I; Hustache-Mathieu L; Brégigeon S; Makinson A; Rey D;
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):1065-1073. PubMed ID: 31953902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
    Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
    Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era.
    Dinh S; Malmström S; Möller IK; Yilmaz A; Svedhem V; Carlander C
    AIDS; 2023 Nov; 37(13):2041-2048. PubMed ID: 37451428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
    Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
    J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Franceschi S; Maso LD; Rickenbach M; Polesel J; Hirschel B; Cavassini M; Bordoni A; Elzi L; Ess S; Jundt G; Mueller N; Clifford GM
    Br J Cancer; 2008 Sep; 99(5):800-4. PubMed ID: 18665172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.
    Kowalkowski MA; Kramer JR; Richardson PR; Suteria I; Chiao EY
    Clin Infect Dis; 2015 May; 60(9):1405-14. PubMed ID: 25586682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
    Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
    BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.
    Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P
    Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Kaposi sarcoma in children with HIV-1 infection.
    Anglemyer A; Agrawal AK; Rutherford GW
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Retrospective Study on Changing Trends of Acquired Immunodeficiency Syndrome related Kaposi's Sarcoma in North-Western Nigeria.
    Adeiza MA; Abdullahi U
    West Afr J Med; 2022 Jul; 39(7):663-669. PubMed ID: 35921757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
    Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
    PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Kaposi Sarcoma on Quality of Life Amongst HIV-infected Adults Initiating Antiretroviral Therapy in East Africa.
    Scott L; Laker-Oketta M; Byakwaga H; Glidden D; Mwebesa B; Muzoora C; Maurer T; Assenzio M; Hunt P; Bangsberg D; Haberer J; Martin J
    medRxiv; 2023 Jul; ():. PubMed ID: 37546765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].
    Klingenberg RE; Esser S; Brockmeyer NH; Michalik C; Skaletz-Rorowski A; Potthoff A;
    Hautarzt; 2018 Feb; 69(2):143-148. PubMed ID: 29101417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men.
    Luu HN; Amirian ES; Chiao EY; Scheurer ME
    Cancer Med; 2014 Dec; 3(6):1635-43. PubMed ID: 25139791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
    Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
    J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
    Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
    PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of Kaposi's sarcoma and associated mortality in Fresno, California, 1998 to 2012.
    Mu A; Rutledge J; Mills P; Paul S
    J Int Assoc Provid AIDS Care; 2014; 13(6):526-8. PubMed ID: 24739208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.